VT
ONC

Vise Technologies’s BeOne Medicines Ltd ONC Stock Holding History

Vise Technologies’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Hold
924
– – 0.01% 1182
2025
Q4 		$281K Buy
924
+144
+18% +$47.1K 0.01% 1190
2025
Q3 		$266K Buy
+780
New +$237K 0.01% 968
2024
Q4 		$249K Buy
+1,346
New +$275K 0.02% 683

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vise Technologies's ONC Position: Q1 2026 in Review

Vise Technologies held its BeOne Medicines Ltd (ONC) position steady in Q1 2026 at 924 shares worth $281K. The position accounts for 0.01% of the portfolio, ranked #1182.

Vise Technologies first reported a position in ONC in Q4 2024 and has held it in 4 quarters since. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Vise Technologies held 924 shares of BeOne Medicines Ltd worth $281K as of Q1 2026.
  • Vise Technologies left its BeOne Medicines Ltd share count unchanged in Q1 2026.
  • BeOne Medicines Ltd made up 0.01% of Vise Technologies's portfolio in Q1 2026, its #1182 holding.
  • Vise Technologies first reported a position in BeOne Medicines Ltd in Q4 2024 and has held it in 4 quarters since.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.